Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of IBI318 monotherapy for relapsed/refractory extranodal NK/T cell lymphoma (nasal type).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04602065
Study type Interventional
Source Innovent Biologics (Suzhou) Co. Ltd.
Contact
Status Terminated
Phase Phase 1/Phase 2
Start date November 24, 2020
Completion date February 28, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05475925 - A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas Phase 1/Phase 2